Fidelis Capital Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-818
Closed -$216K – 453
2025
Q1
$216K Sell
818
-67
-8% -$18.1K 0.02% 397
2024
Q4
$259K Buy
+885
New +$237K 0.03% 364
2024
Q3
– Sell
-981
Closed -$339K – 422
2024
Q2
$339K Buy
981
+71
+8% +$24K 0.05% 264
2024
Q1
$316K Sell
910
-92
-9% -$34.9K 0.05% 282
2023
Q4
$459K Buy
1,002
+145
+17% +$71.5K 0.1% 179
2023
Q3
$417K Buy
857
+98
+13% +$46.1K 0.14% 149
2023
Q2
$339K Buy
759
+17
+2% +$8.56K 0.12% 175
2023
Q1
$397K Buy
742
+317
+75% +$157K 0.17% 142
2022
Q4
$205K Buy
+425
New +$223K 0.24% 109

Other funds holding HUM

Fidelis Capital Partners's HUM Position: Q2 2025 in Review

Fidelis Capital Partners sold out of Humana (HUM) in Q2 2025, closing a stake of 818 shares — an estimated $216K sold.

Fidelis Capital Partners first reported a position in HUM in Q4 2022 and held it in 9 quarters. The position peaked at $459K in Q4 2023. 879 funds tracked by Wall St. Rank hold HUM as of Q2 2025.

  • Fidelis Capital Partners reported no remaining Humana position as of Q2 2025 after selling out during the quarter.
  • Fidelis Capital Partners sold 818 Humana shares in Q2 2025, an estimated $216K.
  • Fidelis Capital Partners first reported a position in Humana in Q4 2022 and held it in 9 quarters.
  • Fidelis Capital Partners's Humana position peaked at $459K in Q4 2023.
  • 879 funds tracked by Wall St. Rank held Humana as of Q2 2025.

Based on Fidelis Capital Partners's 13F filing for Q2 2025, filed 7 Aug 2025.